id
stringlengths 1
5
| question_id
stringlengths 1
5
| document_id
stringlengths 5
7
| question
stringlengths 55
970
| type
stringclasses 1
value | choices
list | context
stringlengths 0
971
| answer
sequence |
---|---|---|---|---|---|---|---|
10000 | 13812 | 3661555 | Compared to usual care what was the result of work support intervention aimed at enhancing return-to-work on Return-to-work rates? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Return-to-work rates were 86% and 83% (p = 0.6) for the intervention group and control group when excluding 8 patients who died or with a life expectancy of months at follow-up. | [
"no significant difference"
] |
10001 | 13813 | 3661555 | Compared to usual care what was the result of work support intervention aimed at enhancing return-to-work on Median time from initial sick leave to partial return-to-work? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Return-to-work rates were 86% and 83% (p = 0.6) for the intervention group and control group when excluding 8 patients who died or with a life expectancy of months at follow-up. | [
"no significant difference"
] |
10002 | 13814 | 3661555 | Compared to usual care what was the result of work support intervention aimed at enhancing return-to-work on Quality of life and work ability? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Return-to-work rates were 86% and 83% (p = 0.6) for the intervention group and control group when excluding 8 patients who died or with a life expectancy of months at follow-up. | [
"no significant difference"
] |
10003 | 13815 | 3661555 | Compared to usual care what was the result of work support intervention aimed at enhancing return-to-work on Work functioning and costs? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Return-to-work rates were 86% and 83% (p = 0.6) for the intervention group and control group when excluding 8 patients who died or with a life expectancy of months at follow-up. | [
"no significant difference"
] |
10004 | 13816 | 5435086 | Compared to budesonide/formoterol with salbutamol what was the result of budesonide/formoterol inhaler on the number of high use days without medical review within 48 h? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | In the SMART regimen, the number of high use days without medical review within 48 h was approximately half of that in the Standard regimen; relative rate (95% CI) 0·49 (0·31 to 0·75), P = 0·001 (Fig. 1, Table 2a). | [
"significantly decreased"
] |
10005 | 13817 | 5435086 | Compared to budesonide/formoterol with salbutamol what was the result of budesonide/formoterol inhaler on relative rate? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | In the SMART regimen, the number of high use days without medical review within 48 h was approximately half of that in the Standard regimen; relative rate (95% CI) 0·49 (0·31 to 0·75), P = 0·001 (Fig. 1, Table 2a). | [
"significantly increased"
] |
10006 | 13818 | 5244530 | Compared to treatment as usual (TAU) what was the result of person-centred general practitioners (GP) consultations on depression severity reduction, remission rate, change in quality of life, psychological well-being, sedative prescriptions, sick leave? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There were no significant differences between the intervention and control group in depression severity reduction or remission rate, change in quality of life, psychological well-being, sedative prescriptions, or sick leave during the whole 12-month follow-up. | [
"no significant difference"
] |
10007 | 13819 | 5244530 | Compared to treatment as usual (TAU) what was the result of person-centred general practitioners (GP) consultations on continued antidepressants until the 6 month? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There were no significant differences between the intervention and control group in depression severity reduction or remission rate, change in quality of life, psychological well-being, sedative prescriptions, or sick leave during the whole 12-month follow-up. | [
"significantly increased"
] |
10008 | 13823 | 3724383 | Compared to mineral oil alone what was the result of synbiotic (Lactol®, composed of Lactobacillus Sporogenes, 1 Tab/20 kg/d) plus mineral oil (Paraffin 1 ml/kg/d) on stool frequency? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | After the treatment, stool frequency increased in both groups (P < 0.001), with greater increase in synbiotic + mineral oil group (P = 0.001). | [
"significantly increased"
] |
10009 | 13824 | 3724383 | Compared to mineral oil alone what was the result of synbiotic (Lactol®, composed of Lactobacillus Sporogenes, 1 Tab/20 kg/d) plus mineral oil (Paraffin 1 ml/kg/d) on Straining at defecation, incomplete evacuation, and soiling? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | After the treatment, stool frequency increased in both groups (P < 0.001), with greater increase in synbiotic + mineral oil group (P = 0.001). | [
"significantly decreased"
] |
10010 | 13825 | 3724383 | Compared to mineral oil alone what was the result of synbiotic (Lactol®, composed of Lactobacillus Sporogenes, 1 Tab/20 kg/d) plus mineral oil (Paraffin 1 ml/kg/d) on better global improvement? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | After the treatment, stool frequency increased in both groups (P < 0.001), with greater increase in synbiotic + mineral oil group (P = 0.001). | [
"significantly increased"
] |
10011 | 13826 | 3724383 | Compared to mineral oil alone what was the result of synbiotic (Lactol®, composed of Lactobacillus Sporogenes, 1 Tab/20 kg/d) plus mineral oil (Paraffin 1 ml/kg/d) on severe side-effects? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | After the treatment, stool frequency increased in both groups (P < 0.001), with greater increase in synbiotic + mineral oil group (P = 0.001). | [
"no significant difference"
] |
10012 | 13827 | 4218764 | Compared to saline at the same scheme of administration what was the result of 10-mL bolus of 0.2% ropivacaine before emergence, followed by a continuous infusion of 6 mL/h for 24 hours (PVB group) on The cumulative sufentanil consumption? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The cumulative sufentanil consumption in the PVB group (54.3 ± 12.1 μg) at 24 postoperative hours was more than 20% less than that of the control group (68.1 ± 9.9 μg) (P < 0.001 | [
"significantly decreased"
] |
10013 | 13828 | 4218764 | Compared to saline at the same scheme of administration what was the result of 10-mL bolus of 0.2% ropivacaine before emergence, followed by a continuous infusion of 6 mL/h for 24 hours (PVB group) on pain scores (numerical rating scale)? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The cumulative sufentanil consumption in the PVB group (54.3 ± 12.1 μg) at 24 postoperative hours was more than 20% less than that of the control group (68.1 ± 9.9 μg) (P < 0.001 | [
"significantly decreased"
] |
10014 | 13829 | 3664327 | Compared to computerized implicit perspective taking task what was the result of empathy scenario and recorded self-reports of empathic reactions to the scenario on effect on empathic concern, personal distress ratings? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The MANOVA showed that OT (vs. placebo) had no effect on empathic concern, F(1, 90) = 0.16, p = 0.69, or personal distress ratings, F(1, 90) = 0, p = 0.99. | [
"no significant difference"
] |
10015 | 13831 | 4210722 | Compared to no further reminder (IG1); what was the result of a separate reminder card 4 days before the appointment (IG3); reminder card together with the appointment letter (IG2); on use of a reminder card? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Overall, the use of a reminder card had a positive but not significant effect as 89 % (185/209) of participants who received the reminder card submitted vaccination data versus 81 % (84/104) of participants who did not receive any reminder card (p = 0.06). | [
"no significant difference"
] |
10016 | 13832 | 3634264 | Compared to placebo what was the result of 1500 mg/dialysis interval (every other day) oral L-carnitine on flow mediated dilation? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | This study showed that after one month of L-carnitine or placebo therapy there was no significant improvement in flow mediated dilation (p = 0.80 and p = 0.59, respectively) | [
"no significant difference"
] |
10017 | 13833 | 3634264 | Compared to placebo what was the result of 1500 mg/dialysis interval (every other day) oral L-carnitine on carotid intima-media thickness? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | This study showed that after one month of L-carnitine or placebo therapy there was no significant improvement in flow mediated dilation (p = 0.80 and p = 0.59, respectively) | [
"no significant difference"
] |
10018 | 13834 | 5988794 | Compared to personalised hip therapy what was the result of hip arthroscopy on SF-12(12-item Short Form Health Survey), EQ-5D-5L scores at 6 or 12 months? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There were no significant between-group differences in SF-12 or EQ-5D-5L scores at 6 or 12 months after randomisation (table 2).Figure 2 | [
"no significant difference"
] |
10019 | 13835 | 5988794 | Compared to personalised hip therapy what was the result of hip arthroscopy on International Hip Outcome Tool (iHOT-33)? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There were no significant between-group differences in SF-12 or EQ-5D-5L scores at 6 or 12 months after randomisation (table 2).Figure 2 | [
"no significant difference"
] |
10020 | 13841 | 5777424 | Compared to placebo what was the result of Etodolac (400 mg) on tooth sensitivity risk? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The treatment that patients received prior to the bleaching procedure did not affect the risk to sensitivity at any of the moments of evaluation (during and immediately after: p=1.0; after 24 hours: p=0.683). | [
"no significant difference"
] |
10021 | 13842 | 5777424 | Compared to placebo what was the result of Etodolac (400 mg) on bleaching effectiveness? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The treatment that patients received prior to the bleaching procedure did not affect the risk to sensitivity at any of the moments of evaluation (during and immediately after: p=1.0; after 24 hours: p=0.683). | [
"no significant difference"
] |
10022 | 13843 | 3682309 | Compared to continuous venovenous hemodialysis [CVVHD] what was the result of continuous venovenous hemofiltration [CVVH] on Duration RRT prescribed, hrs? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Duration RRT prescribed, hrs
146 ± 240
145 ± 156
0.88 | [
"no significant difference"
] |
10023 | 13844 | 3682309 | Compared to continuous venovenous hemodialysis [CVVHD] what was the result of continuous venovenous hemofiltration [CVVH] on Duration RRT received? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Duration RRT prescribed, hrs
146 ± 240
145 ± 156
0.88 | [
"no significant difference"
] |
10024 | 13845 | 3682309 | Compared to continuous venovenous hemodialysis [CVVHD] what was the result of continuous venovenous hemofiltration [CVVH] on Mean RRT dose? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Duration RRT prescribed, hrs
146 ± 240
145 ± 156
0.88 | [
"no significant difference"
] |
10025 | 13846 | 3682309 | Compared to continuous venovenous hemodialysis [CVVHD] what was the result of continuous venovenous hemofiltration [CVVH] on Prescribed dose delivered, %? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Duration RRT prescribed, hrs
146 ± 240
145 ± 156
0.88 | [
"no significant difference"
] |
10026 | 13847 | 3682309 | Compared to continuous venovenous hemodialysis [CVVHD] what was the result of continuous venovenous hemofiltration [CVVH] on Net ultrafiltration, L/day? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Duration RRT prescribed, hrs
146 ± 240
145 ± 156
0.88 | [
"no significant difference"
] |
10027 | 13851 | 1849920 | Compared to composite group (0.9 vs. 0.6 μg/g creatinine) what was the result of amalgam group on number of restored surfaces? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | At the end of the follow-up period, the number of restored surfaces in place ranged from 0 to 36 in both treatment groups, and the mean values did not differ significantly (p = 0.16) | [
"no significant difference"
] |
10028 | 13852 | 1849920 | Compared to composite group (0.9 vs. 0.6 μg/g creatinine) what was the result of amalgam group on cumulative number of restored surfaces? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | At the end of the follow-up period, the number of restored surfaces in place ranged from 0 to 36 in both treatment groups, and the mean values did not differ significantly (p = 0.16) | [
"no significant difference"
] |
10029 | 13853 | 1849920 | Compared to composite group 0.6 μg/g what was the result of amalgam group 0.9 on mean urinary mercury concentration? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | At the end of the follow-up period, the number of restored surfaces in place ranged from 0 to 36 in both treatment groups, and the mean values did not differ significantly (p = 0.16) | [
"no significant difference"
] |
10030 | 13854 | 3646875 | Compared to untrained group what was the result of training on different topics in ontology development on similarity of the students’ ontology artefacts compared with gold standard ontologies developed by the authors before the experiment; secondary outcome was the intra-group similarity of group members’ ontologies? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | the ontologies developed after specific training were only slightly but not significantly closer to the gold standard ontologies than the ontologies developed without prior specific training; | [
"no significant difference"
] |
10031 | 13855 | 5769202 | Compared to Trataka Yoga Kriya what was the result of Bates eye exercise therapy on refractive errors, visual acuity? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Results obtained revealed that both Bates exercises and Trataka Yoga Kriya were not significantly effective in reducing refractive errors and in improving visual acuity (P value of refractive error in right eye: 0.4250; left eye: 0.4596; P value of visual acuity in right eye: 0.5691; left eye: 0.8952) | [
"no significant difference"
] |
10032 | 13856 | 5850179 | Compared to no‐morphine what was the result of morphine on major adverse cardiovascular event? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There was no significant difference in major adverse cardiovascular events between patients who received morphine compared with those who did not (26.2% versus 22.0%, respectively; P=0.15). | [
"no significant difference"
] |
10033 | 13857 | 5850179 | Compared to no‐morphine what was the result of morphine on The all‐cause mortality? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There was no significant difference in major adverse cardiovascular events between patients who received morphine compared with those who did not (26.2% versus 22.0%, respectively; P=0.15). | [
"no significant difference"
] |
10034 | 13858 | 5850179 | Compared to no‐morphine what was the result of morphine on infarct size? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There was no significant difference in major adverse cardiovascular events between patients who received morphine compared with those who did not (26.2% versus 22.0%, respectively; P=0.15). | [
"no significant difference"
] |
10035 | 13860 | 4990415 | Compared to dietary counseling what was the result of Group Support Lifestyle Modification (GSLiM) on Systolic blood pressure, Diastolic blood pressure? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Table 6 summarises obesity and cardiovascular measures from baseline to 12th week, 13th to 24th week, baseline to 24th week and from 25th week to 36th week. No other significant mean difference between groups observed at any of the time intervals. | [
"no significant difference"
] |
10036 | 13861 | 4990415 | Compared to dietary counseling what was the result of Group Support Lifestyle Modification (GSLiM) on Negative emotions? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Table 6 summarises obesity and cardiovascular measures from baseline to 12th week, 13th to 24th week, baseline to 24th week and from 25th week to 36th week. No other significant mean difference between groups observed at any of the time intervals. | [
"significantly decreased"
] |
10037 | 13862 | 4990415 | Compared to dietary counseling what was the result of Group Support Lifestyle Modification (GSLiM) on Physical Discomfort? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Table 6 summarises obesity and cardiovascular measures from baseline to 12th week, 13th to 24th week, baseline to 24th week and from 25th week to 36th week. No other significant mean difference between groups observed at any of the time intervals. | [
"significantly decreased"
] |
10038 | 13863 | 4990415 | Compared to dietary counseling what was the result of Group Support Lifestyle Modification (GSLiM) on Total WEL score? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Table 6 summarises obesity and cardiovascular measures from baseline to 12th week, 13th to 24th week, baseline to 24th week and from 25th week to 36th week. No other significant mean difference between groups observed at any of the time intervals. | [
"significantly increased"
] |
10039 | 13864 | 1174954 | Compared to placebo what was the result of risedronate 15 mg on Western Ontario and McMaster Universities (WOMAC) OA index, particularly of physical function, patient global assessment ? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Those receiving risedronate at 15 mg showed improvement of the WOMAC index, particularly of physical function, significant improvement of the patient global assessment (P < 0.001 | [
"significantly increased"
] |
10040 | 13865 | 1174954 | Compared to risedronate 15 mg what was the result of risedronate 5 mg on joint-space width? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Those receiving risedronate at 15 mg showed improvement of the WOMAC index, particularly of physical function, significant improvement of the patient global assessment (P < 0.001 | [
"no significant difference"
] |
10041 | 13866 | 1174954 | Compared to placebo what was the result of risedronate 5 mg, risedronate 15 mg on cartilage degradation and bone resorption? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Those receiving risedronate at 15 mg showed improvement of the WOMAC index, particularly of physical function, significant improvement of the patient global assessment (P < 0.001 | [
"no significant difference"
] |
10042 | 13867 | 5096778 | Compared to placebo what was the result of ibudilast (40 mg twice daily) on the number of capsules returned? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There was no treatment group difference (P=0.6) with the number of capsules returned (placebo vs ibudilast [mean {SD}: 2.4 {2.4} vs 7.7 {15.6}]). | [
"no significant difference"
] |
10043 | 13868 | 5096778 | Compared to placebo what was the result of ibudilast (40 mg twice daily) on frequency of moderate to severe headaches 5-8 weeks? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There was no treatment group difference (P=0.6) with the number of capsules returned (placebo vs ibudilast [mean {SD}: 2.4 {2.4} vs 7.7 {15.6}]). | [
"significantly decreased"
] |
10044 | 13870 | 5096778 | Compared to placebo what was the result of ibudilast (40 mg twice daily) on frequency intake of symptomatic medication? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There was no treatment group difference (P=0.6) with the number of capsules returned (placebo vs ibudilast [mean {SD}: 2.4 {2.4} vs 7.7 {15.6}]). | [
"no significant difference"
] |
10045 | 13871 | 5739620 | Compared to r doxycycline 100 mg b.i.d. what was the result of erythromycin ointment 2% followed by doxycycline on time to the onset of skin toxicity? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | n the doxycycline arm median time was 43 days (day one of cycle 4), in the erythromycin arm median time was 29 days (day one of cycle 3) without statistical significance in the corresponding logrank test (P =.68). | [
"no significant difference"
] |
10046 | 13872 | 5739620 | Compared to r doxycycline 100 mg b.i.d. what was the result of erythromycin ointment 2% followed by doxycycline on appearance of a moderate to severe skin toxicity? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | n the doxycycline arm median time was 43 days (day one of cycle 4), in the erythromycin arm median time was 29 days (day one of cycle 3) without statistical significance in the corresponding logrank test (P =.68). | [
"no significant difference"
] |
10047 | 13881 | 4390525 | Compared to G3-group after distal stripping without invagination, G4-group after distal stripping with invagination what was the result of G1-group after proximal stripping without invagination, G2-group after proximal stripping with invagination on saphenous nerve lesion? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Best results of treatment were observed in group G4 (distal stripping with vein invagination) where no statistically significant consequences of nerve injury were detected. | [
"no significant difference"
] |
10048 | 13882 | 4390525 | Compared to G4-group after distal stripping with invagination what was the result of G1-group after proximal stripping without invagination on saphenous nerve sensory perception abnormalities? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Best results of treatment were observed in group G4 (distal stripping with vein invagination) where no statistically significant consequences of nerve injury were detected. | [
"significantly increased"
] |
10049 | 13883 | 4627615 | Compared to control what was the result of buccal spray; on 25(OH)D concentration? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | When control group in healthy subjects was compared with their corresponding treatment groups, it was found that the difference of mean between control group and buccal spray group was 7.47 (95 % CI, 5.27, 9.67) which was significant (p < 0.05) | [
"significantly increased"
] |
10050 | 13884 | 4627615 | Compared to control what was the result of soft gelatin capsule on 25(OH)D concentration? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | When control group in healthy subjects was compared with their corresponding treatment groups, it was found that the difference of mean between control group and buccal spray group was 7.47 (95 % CI, 5.27, 9.67) which was significant (p < 0.05) | [
"significantly increased"
] |
10051 | 13885 | 4627615 | Compared to control what was the result of soft gelatin capsule on adverse event? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | When control group in healthy subjects was compared with their corresponding treatment groups, it was found that the difference of mean between control group and buccal spray group was 7.47 (95 % CI, 5.27, 9.67) which was significant (p < 0.05) | [
"no significant difference"
] |
10052 | 13886 | 4736250 | Compared to control group what was the result of screened for metabolic syndrome on self-reported moderate intensity MET? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | After controlling for potential confounders, the intervention group achieved a marginally significant improvement in the self-reported moderate intensity MET minutes per week (p = 0.049) relative to the control group | [
"significantly increased"
] |
10053 | 13887 | 4736250 | Compared to control group what was the result of screened for metabolic syndrome on fibre intake score, fat intake score, fruit intake, and vegetable intake? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | After controlling for potential confounders, the intervention group achieved a marginally significant improvement in the self-reported moderate intensity MET minutes per week (p = 0.049) relative to the control group | [
"significantly increased"
] |
10054 | 13888 | 5753932 | Compared to body-weight supported treadmill room (21°C) what was the result of body-weight supported treadmill cool (16°C) on maximum voluntary contraction force; stabilized body temperature? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Exercise in cooler room temperature increased maximum voluntary contraction force (p = 0.010) and stabilized body temperature (p = 0.011) compared to standard room temperature. | [
"significantly increased"
] |
10055 | 13891 | 3398966 | Compared to the usual care afforded to traditional Medicare beneficiaries what was the result of the HQP model of community-based nurse care management. on Mortality? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Overall, 86 (9.9%) intervention participants and 111 (12.9%) control participants died during the study period, representing a 25% lower relative risk of death (unadjusted hazard ratio [HR] 0.75 [95% CI 0.57–1.00], p = 0.047) among the intervention group. | [
"significantly decreased"
] |